Abstract
Intracellular pathogens like Salmonella evade host phagocytic killing by various mechanisms. Classical antimicrobial therapy requires multiple dosages and frequent administration of drugs for a long duration. Intracellular delivery of antimicrobials using nanoparticle may effectively devise therapies for bacterial infections. This review will address the mechanisms used by Salmonella to avoid host pathogenic killing, reasons for therapeutic failure and advances in nanoparticle drug delivery technology for efficient intracellular bacterial clearance. © 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Ranjan, A., Pothayee, N., Seleem, M. N., Boyle, S. M., Kasimanickam, R., Riffle, J. S., & Sriranganathan, N. (2012). Nanomedicine for intracellular therapy. FEMS Microbiology Letters, 332(1), 1–9. https://doi.org/10.1111/j.1574-6968.2012.02566.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.